+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

IncellDx Inc - Product Pipeline Analysis, 2021 Update

  • ID: 5367325
  • Company Profile
  • June 2021
  • 29 pages
  • GlobalData

FEATURED COMPANIES

  • Genomix Biotech Inc
  • InterMed PA
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

IncellDx Inc (IncellDx) is a single cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies. The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ transplant rejection. Its products comprise HIV viral reservoirs probes, HIV tropism probes, HCV viral reservoirs probes, EBV viral reservoirs probes, E6 and E7 mRNA kits, E6 and E7 mRNA probes, fixative permeabilization reagents, core reagents, and HPV positive control and HPV negative control products. The company markets its products across Greece, Spain, China, India and the US. IncellDx is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company IncellDx Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Genomix Biotech Inc
  • InterMed PA
  • MORE
IncellDx Inc Company Overview
  • IncellDx Inc Company Snapshot
  • IncellDx Inc Pipeline Products and Ongoing Clinical Trials Overview
  • IncellDx Inc - Pipeline Analysis Overview
  • IncellDx Inc - Key Facts
  • IncellDx Inc - Major Products and Services
  • IncellDx Inc Pipeline Products by Development Stage
IncellDx Inc Pipeline Products Overview
  • CCR5 Receptor Occupancy Assay
  • CCR5 Receptor Occupancy Assay Product Overview
  • COVID-19 - Cytokine Storm Cytokine Panel
  • COVID-19 - Cytokine Storm Cytokine Panel Product Overview
  • Diagnostic Test - Breast Cancer
  • Diagnostic Test - Breast Cancer Product Overview
  • Diagnostic Test - Ovarian Cancer
  • Diagnostic Test - Ovarian Cancer Product Overview
  • HPV OncoTect 3Dx
  • HPV OncoTect 3Dx Product Overview
  • Machine Learning Algorithm - COVID-19
  • Machine Learning Algorithm - COVID-19 Product Overview
  • Machine Learning Algorithm - Cytokine/Chemokine Immune Panel
  • Machine Learning Algorithm - Cytokine/Chemokine Immune Panel Product Overview
  • OncoTect iO Bladder Cancer Kit
  • OncoTect iO Bladder Cancer Kit Product Overview
IncellDx Inc - Key Competitors

IncellDx Inc - Key Employees

IncellDx Inc - Locations and Subsidiaries
  • Head Office
Recent Developments
  • IncellDx Inc, Recent Developments
  • Jun 18, 2020: IncellDx files patent for CCL5/RANTES utility as a diagnostic, prognostic, and therapeutic biomarker in COVID-19 and other cytokine storm conditions
  • Mar 21, 2018: GIMDx and IncellDx Announce Acceleration of Chinese Commercialization of HPV OncoTect Kit
  • Jan 17, 2018: Premas, IncellDx Ink India Distribution Agreement
  • Mar 30, 2017: IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO Assay
  • Oct 04, 2016: IncellDx’s Quantitative Immuno-Oncology Assay OncoTect iO Published in New Study
  • Jan 27, 2015: MD Anderson and PPRI in Early Stage Breast Cancer Studies with IncellDx OncoBreast3Dx Technology
  • Feb 25, 2014: IncellDx Announces the Expansion of its Companion Diagnostic Program
  • Jun 21, 2013: IncellDx Signs Deal With GeneCell Diagnostics To Offer New HPV Technology In India
  • Jan 08, 2013: IncellDx Presents First Study Using Its New OncoBreast 3Dx Breast Cancer Technology
  • Oct 21, 2011: IncellDx Issues Statement About USPSTF New Cancer Screening Recommendations
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • IncellDx Inc Pipeline Products and Ongoing Clinical Trials Overview
  • IncellDx Inc Pipeline Products by Equipment Type
  • IncellDx Inc Pipeline Products by Indication
  • IncellDx Inc, Key Facts
  • IncellDx Inc, Major Products and Services
  • IncellDx Inc Number of Pipeline Products by Development Stage
  • IncellDx Inc Pipeline Products Summary by Development Stage
  • CCR5 Receptor Occupancy Assay - Product Status
  • CCR5 Receptor Occupancy Assay - Product Description
  • COVID-19 - Cytokine Storm Cytokine Panel - Product Status
  • COVID-19 - Cytokine Storm Cytokine Panel - Product Description
  • Diagnostic Test - Breast Cancer - Product Status
  • Diagnostic Test - Breast Cancer - Product Description
  • Diagnostic Test - Ovarian Cancer - Product Status
  • Diagnostic Test - Ovarian Cancer - Product Description
  • HPV OncoTect 3Dx - Product Status
  • HPV OncoTect 3Dx - Product Description
  • Machine Learning Algorithm - COVID-19 - Product Status
  • Machine Learning Algorithm - COVID-19 - Product Description
  • Machine Learning Algorithm - Cytokine/Chemokine Immune Panel - Product Status
  • Machine Learning Algorithm - Cytokine/Chemokine Immune Panel - Product Description
  • OncoTect iO Bladder Cancer Kit - Product Status
  • OncoTect iO Bladder Cancer Kit - Product Description
IncellDx Inc, Key Employees
  • Glossary
List of Figures
  • IncellDx Inc Pipeline Products by Equipment Type
  • IncellDx Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Genomix Biotech Inc
  • InterMed PA
  • Clarient Diagnostic Services, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll